Citadel Advisors’s Bionano Genomics BNGO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Hold |
0
| – | – | – | 5994 |
|
|
2024
Q4 | – | Sell |
-4,151
| Closed | -$113K | – | 6014 |
|
|
2024
Q3 | $113K | Buy |
+4,151
| New | +$113K | ﹤0.01% | 4877 |
|
|
2024
Q2 | – | Sell |
-4,004
| Closed | -$267K | – | 5816 |
|
|
2024
Q1 | $267K | Buy |
4,004
+634
| +19% | +$42.2K | ﹤0.01% | 4520 |
|
|
2023
Q4 | $382K | Buy |
3,370
+3,038
| +915% | +$345K | ﹤0.01% | 4007 |
|
|
2023
Q3 | $60.3K | Buy |
+332
| New | +$60.3K | ﹤0.01% | 5009 |
|
|
2023
Q2 | – | Sell |
-899
| Closed | -$599K | – | 5825 |
|
|
2023
Q1 | $599K | Sell |
899
-2,368
| -72% | -$1.58M | ﹤0.01% | 3699 |
|
|
2022
Q4 | $2.86M | Buy |
3,267
+1,259
| +63% | +$1.1M | ﹤0.01% | 2265 |
|
|
2022
Q3 | $2.21M | Sell |
2,008
-1,340
| -40% | -$1.47M | ﹤0.01% | 2650 |
|
|
2022
Q2 | $2.77M | Buy |
3,348
+2,061
| +160% | +$1.71M | ﹤0.01% | 2419 |
|
|
2022
Q1 | $1.99M | Sell |
1,287
-4,503
| -78% | -$6.97M | ﹤0.01% | 3010 |
|
|
2021
Q4 | $10.4M | Buy |
5,790
+5,354
| +1,228% | +$9.6M | ﹤0.01% | 1426 |
|
|
2021
Q3 | $1.44M | Buy |
436
+180
| +70% | +$593K | ﹤0.01% | 3375 |
|
|
2021
Q2 | $1.13M | Sell |
256
-3,942
| -94% | -$17.3M | ﹤0.01% | 3873 |
|
|
2021
Q1 | $20.4M | Buy |
+4,198
| New | +$20.4M | 0.01% | 922 |
|
|
2020
Q4 | – | Sell |
-71
| Closed | -$28K | – | 5075 |
|
|
2020
Q3 | $28K | Sell |
71
-296
| -81% | -$117K | ﹤0.01% | 4488 |
|
|
2020
Q2 | $112K | Buy |
+367
| New | +$112K | ﹤0.01% | 4218 |
|